Signaling in H2O2-induced increase in cell proliferation in Barrett's esophageal adenocarcinoma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 1, 2011, Pages 218-227

  Zhou, Xiaoxu ^a,b   Li, Dan ^a,b   Resnick, Murray B ^a   Behar, Jose ^a   Wands, Jack ^a   Cao, Weibiao ^a  

^a BROWN UNIVERSITY   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P50; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; THYMIDINE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; FLAVONOID; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NOX5 PROTEIN, HUMAN;

ARTICLE; BARRETT ESOPHAGUS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ESOPHAGEAL ADENOCARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ADENOCARCINOMA; DRUG ANTAGONISM; ESOPHAGUS TUMOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; ESOPHAGEAL NEOPLASMS; FLAVONOIDS; HUMANS; HYDROGEN PEROXIDE; LUCIFERASES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NADPH OXIDASE; NF-KAPPA B; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; THYMIDINE; TRANSFECTION;

EID: 80053162485     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.182352     Document Type: Article

References (40)

1. Ballard DW, Dixon EP, Peffer NJ, Bogerd H, Doerre S, Stein B, and Greene WC (1992) The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci USA 89:1875-1879.
2. + channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 287:138-142.
3. Blot WJ and McLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26 (5 Suppl 15):2-8. (Pubitemid 29529530)
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Cao W, Sohn UD, Bitar KN, Behar J, Biancani P, and Harnett KM (2003) MAPK mediates PKC-dependent contraction of cat esophageal and lower esophageal sphincter circular smooth muscle. Am J Physiol Gastrointest Liver Physiol 285: G86-G95. (Pubitemid 36736392)
6. Chandrakesan P, Ahmed I, Anwar T, Wang Y, Sarkar S, Singh P, Peleg S, and Umar S (2010) Novel changes in NF-κB activity during progression and regression phases of hyperplasia: role of MEK, ERK, and p38. J Biol Chem 285: 33485-33498.
7. De Bosscher K, Vanden Berghe W, and Haegeman G (2006) Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25:6868-6886. (Pubitemid 44657857)
8. Farhadi A, Fields J, Banan A, and Keshavarzian A (2002) Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer? Am J Gastroenterol 97:22-26. (Pubitemid 34059759)
9. Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, and Packer L (1997) Redox regulation of NF-kappa B activation. Free Radic Biol Med 22:1115-1126. (Pubitemid 27084148)
10. Fu X, Beer DG, Behar J, Wands J, Lambeth D, and Cao W (2006) cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 281:20368-20382. (Pubitemid 44065811)
11. Gioeli D, Mandell JW, Petroni GR, Frierson HF Jr, and Weber MJ (1999) Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 59:279-284. (Pubitemid 29048852)
12. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, and Karin M (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296. (Pubitemid 39061110)
13. Haggitt RC (1994) Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 25:982-993.
14. Hong J, Behar J, Wands J, Resnick M, Wang LJ, Delellis RA, Lambeth D, and Cao W (2010a) Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S. Cancer Res 70:1247-1255.
15. Hong J, Behar J, Wands J, Resnick M, Wang LJ, DeLellis RA, Lambeth D, Souza RF, Spechler SJ, and Cao W (2010b) Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 59:170-180.
16. Hong J, Resnick M, Behar J, Wands J, Delellis RA, and Cao W (2011) Role of RAC1 in regulation of NOX5-S function in Barrett's esophageal adenocarcinoma cells. Am J Physiol Cell Physiol 301:C413-C420.
17. Hong J, Resnick M, Behar J, Wang LJ, Wands J, DeLellis RA, Souza RF, Spechler SJ, and Cao W (2010c) Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S. Am J Physiol Gastrointest Liver Physiol 299:G697-G706.
18. Hoshino R, Chatani Y, Yamori T, Tsuruo T, Oka H, Yoshida O, Shimada Y, Ari-i S, Wada H, Fujimoto J, et al. (1999) Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 18: 813-822. (Pubitemid 29080340)
19. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, and Edwards BK (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93:824-842. (Pubitemid 32586611)
20. Hughes SJ, Nambu Y, Soldes OS, Hamstra D, Rehemtulla A, Iannettoni MD, Orringer MB, and Beer DG (1997) Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma. Cancer Res 57:5571-5578. (Pubitemid 28006766)
21. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431-436.
22. Karin M, Cao Y, Greten FR, and Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301-310. (Pubitemid 37328783)
23. Kim R, Weissfeld JL, Reynolds JC, and Kuller LH (1997) Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 6:369-377. (Pubitemid 27204029)
24. Kumar B, Koul S, Khandrika L, Meacham RB, and Koul HK (2008) Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 68:1777-1785. (Pubitemid 351416563)
25. Lagergren J, Bergström R, Lindgren A, and Nyrén O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831. (Pubitemid 29142625)
26. Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181-189.
27. Nishimoto S and Nishida E (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7:782-786. (Pubitemid 44275395)
28. Ohshima H, Tatemichi M, and Sawa T (2003) Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417:3-11. (Pubitemid 36960042)
29. Olyaee M, Sontag S, Salman W, Schnell T, Mobarhan S, Eiznhamer D, and Keshavarzian A (1995) Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut 37:168-173.
30. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, and Ben-Neriah Y (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461-466. (Pubitemid 39329586)
31. Pohl H and Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142-146. (Pubitemid 40277094)
32. Shih VF, Tsui R, Caldwell A, and Hoffmann A (2011) A single NFêB system for both canonical and non-canonical signaling. Cell Res 21:86-102.
33. Si J, Fu X, Behar J, Wands J, Beer DG, Souza RF, Spechler SJ, Lambeth D, and Cao W (2007) NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells. J Biol Chem 282:16244-16255. (Pubitemid 47100387)
34. Sihvo EI, Ruohtula T, Auvinen MI, Koivistoinen A, Harjula AL, and Salo JA (2003) Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus. J Thorac Cardiovasc Surg 126: 1952-1957. (Pubitemid 38020757)
35. Souza RF, Shewmake K, Pearson S, Sarosi GA Jr, Feagins LA, Ramirez RD, Terada LS, and Spechler SJ (2004) Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 287:G743-G748. (Pubitemid 39280431)
36. Souza RF, Shewmake K, Terada LS, and Spechler SJ (2002) Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 122:299-307. (Pubitemid 34126346)
37. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79-82.
38. Tanaka S, Chu S, Hirokawa M, Montrose MH, and Kaunitz JD (2003) Direct measurement of acid permeation into rat oesophagus. Gut 52:775-783. (Pubitemid 36613481)
39. Wetscher GJ, Hinder RA, Klingler P, Gadenstatter M, Perdikis G, and Hinder PR (1997) Reflux esophagitis in humans is a free radical event. Dis Esophagus 10: 29-32; discussion 33.
40. Wild CP and Hardie LJ (2003) Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 3:676-684. (Pubitemid 37328822)